Global Companion Animal Vaccines Market, Trends, Applications, Analysis, Growth, and Forecast to 2027

MarketResearch.biz, in its upcoming report titled, “Global Companion Animal Vaccines Market Trends, Applications, Analysis, Growth, and Forecast to 2027”, offers in-depth insights, revenue details, and other vital information regarding the global companion animal vaccines market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global companion animal vaccines market, and their financials, apart from strategies, acquisitions & mergers, and market footprint. The global companion animal vaccines market was valued at more than US$ X, XXX million in 2016 and is projected to register a CAGR of X.X% during the forecast period. The market is expected to be valued at nearly US$ X, XXX million by the end of 2027. The global companion animal vaccines market has been segmented on the basis of product type, specie type, and region.

Companion animal vaccines are used to stimulate an immune response in pets such as dogs, birds and cats, etc. In addition, bite wounds caused by dogs and cats develop many infections in humans. Other diseases such as neoplasia, distemper, parvovirus, leukemia, panleukopenia, and viral rhinotracheitis are sourced from various pet animals. For safety of pets as well as pet owners to protect against such diseases, vaccination has become necessary.

In the recent past, companion animals have become a significant part of urban population. Strengthening of bond between animals and humans have led to demand for veterinary care products. In addition, pharmaceuticals and vaccines have been contributing significantly to companion animals’ health and wellbeing.

Factors driving growth of the global companion animal vaccines market include increasing prevalence of various animal diseases, concerns regarding animal diseases getting transmitted to humans, technological and biotechnological advancements regarding diagnostics and therapeutics with efficient drugs. In addition, rising trend of keeping pet animals, coupled with growing veterinary care awareness among population is anticipated to accelerate the global companion animal vaccines market growth.

Rising cost for storage of companion animal vaccines, lengthy and expensive developing process, and inadequate reporting systems are factors hindering growth of the global companion animal vaccines market.

North America market, dominates the global companion animal vaccines market by holding major share. This is due to rising adoption of companion pets by all aged people for eliminating psychological stress, growing trend of using pets as a status symbol, and increasing expenditure on veterinary care. Asia Pacific market is expected to witness high growth rate as governments of countries in this region are promoting pet ownership programs to educate the owners about the welfare issues of pets.

Global companion animal vaccines market segmentation by product type:

• Attenuated Live Vaccines
• Conjugate Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• Toxoid Vaccines
• DNA Vaccines
• Recombinant Vaccines

Global companion animal vaccines market segmentation by specie type:

• Canine
• Avian
• Feline

Global companion animal vaccines market segmentation by region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

• Merial Inc.
• Bayer Healthcare
• Boehringer Ingelheim
• Novartis Animal Health Inc.
• Merck Animal Health
• Pfizer
• Bioniche Animal Health
• Merck Animal Health
• Heska Corporation
• Virbac